Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Kopriva-Altfahrt, G; Konig, P; Mundle, M; Prischl, F; Roob, JM; Wiesholzer, M; Vychytil, A.
Exit-site care in austrian peritoneal dialysis centers -- a nationwide survey.
Perit Dial Int. 2009; 29(3):330-339 [OPEN ACCESS]
Web of Science PubMed


Autor/innen der Med Uni Graz:
Roob Johannes

Dimensions Citations:

Plum Analytics:
Background: Catheter-associated infections markedly contribute to treatment failure in peritoneal dialysis (PD) patients. There is much controversy surrounding prophylactic strategies to prevent these infections. Methods: In this nationwide multicenter study we analyzed strategies to prevent catheter-associated infections as performed in Austrian PD centers in 2006. A questionnaire was sent to all 23 PD centers in Austria. Results: Ten different catheter models were used in the 332 patients being treated in the 23 Austrian PD centers. Systemic antibiotics prior to catheter placement were given by 17 of the 23 PD centers (glycopeptides, n = 7; cephalosporins, n = 10). Nasal swabs were taken preoperatively by 17 PD centers; nasal Staphylococcus aureus carriers were treated prophylactically with mupirocin cream in 15 of these centers. Dressing change was routinely performed in 318 of 332 chronic PD patients (nonocclusive film dressing, n = 58; gauze dressing, n = 260). Disinfectants for chronic exit-site care included povidone iodine (n = 155), sodium hypochlorite (n = 31), povidone iodine + sodium hypochlorite together (n = 102), and octenidine dihydrochloride/phenoxyethanol (n = 17). Water + non-disinfectant soap or 0.9% sodium chloride was administered as a cleansing agent to the exit site by 27 patients. Routine S. aureus screening (nasal and/or exit-site swabs) in chronic PD patients was performed in 12 PD centers; carriers were treated with mupirocin cream in 11 of these centers. Dialysis staff members were screened for S. aureus in 8 PD centers and spouses were screened for S. aureus in 5 PD centers. The overall exit-site infection rate was 1 episode/43.9 patient-months, tunnel infection rate was 1 episode/88.9 patient-months, and peritonitis rate was 1 episode/51.0 patient-months. Patients of centers that have installed a prophylaxis protocol for treating S. aureus carriers had lower mean infection rates compared with those not using such a protocol. Conclusion: Various individual prophylactic strategies are used to prevent catheter-associated infections in Austrian PD centers. Infection rates are within the range reported in the literature. There is still scope for improvement in some centers (e. g., by establishing a prophylaxis protocol).
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Aged -
Anti-Bacterial Agents - therapeutic use
Anti-Bacterial Agents -
Catheter-Related Infections - diagnosis
Catheters, Indwelling - adverse effects
Device Removal -
Female -
Gram-Negative Bacterial Infections - diagnosis
Gram-Positive Bacterial Infections - diagnosis
Health Care Surveys -
Humans -
Male -
Middle Aged -
Patient Education as Topic -
Peritoneal Dialysis - adverse effects
Physician's Practice Patterns -
Young Adult -

Find related publications in this database (Keywords)
Exit-site infection
tunnel infection
povidone iodine
sodium hypochlorite
tunnel ultrasonography
film dressing
gauze dressing
© Meduni Graz Impressum